A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Start Date
8/1/2026
Completion Date
12/31/2026
Summary
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (within 15 years) who are aged 50-80 with at least a 20 pack-year smoking history. LCS lowers lung cancer death by 20%; however, data shows that LCS completion remains low among minority groups in the United States. The restorative justice-based LCS decision-making support intervention in this trial has been specifically tailored to meet the needs of Black individuals. It is designed to reduce racial unfairness by promoting trust, shared understanding, and empowerment in clinical decision making while addressing the social and historical circumstances of health inequalities. This may be an effective way to increase LCS among Black community members.
Detailed Description
OUTLINE: Participants attend an in-person restorative justice-based LCS decision-making support session over 2-3 hours on study. After completion of study intervention, participants may be followed up at 90 days.
Eligibility Criteria
Age Range: 50 years to 77 years
Interventions
Educational Intervention
Survey Administration
Interview
Electronic Health Record Review
Conditions
Locations
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington 98109
United States